Title:
NOVEL EMPAGLIFLOZIN DERIVATIVE WHICH IS SGLT-2 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2020/242253
Kind Code:
A1
Abstract:
The present invention relates to a novel empagliflozin derivative, which is a novel compound that is useful as an SGLT-2 inhibitor. In addition, a novel empagliflozin derivative according to the present invention exhibits a relatively higher melting point, lower hygroscopicity, and superior storage stability in comparison with empagliflozin, which is a drug developed as an SGLT-2 inhibitor, and thus the present invention is very suitable for manufacturing a formulation.
Inventors:
SUNG SI-YOUNG (KR)
SON BYOUNG-HWA (KR)
ULLAPU PUNNA REDDY (KR)
MOK HUI-YEON (KR)
LIM HONG-GYU (KR)
KIM JEONG-SOO (KR)
SON BYOUNG-HWA (KR)
ULLAPU PUNNA REDDY (KR)
MOK HUI-YEON (KR)
LIM HONG-GYU (KR)
KIM JEONG-SOO (KR)
Application Number:
PCT/KR2020/007019
Publication Date:
December 03, 2020
Filing Date:
May 29, 2020
Export Citation:
Assignee:
DONG A ST CO LTD (KR)
International Classes:
C07H7/06
Domestic Patent References:
| WO2010102512A1 | 2010-09-16 |
Foreign References:
| KR101378320B1 | 2014-03-27 | |||
| US20110077212A1 | 2011-03-31 | |||
| KR101174726B1 | 2012-08-17 | |||
| KR20140027250A | 2014-03-06 |
Attorney, Agent or Firm:
ROH, Jae-Chull (KR)
Download PDF: